Vaccine Development in Japan New Coronavirus March 5 18:51

Amid a series of new coronavirus infections in Japan, it has been revealed that a biotech venture company in Osaka has started developing vaccines. As early as six months later, he wants to conduct clinical trials to administer the drug to humans to confirm safety and efficacy.

Anges, a bio-venture company in Osaka, has held a press conference in Tokyo on May 5 to announce the development of a new coronavirus vaccine.

Vaccines are artificially synthesized DNAs related to proteins on the surface of the virus, which means that we have already started manufacturing vaccines for animal experiments.

As early as six months later, he wants to conduct clinical trials to actually administer the drug to humans to confirm safety and efficacy.

In Japan, other research groups at the National Institute of Infectious Diseases and the University of Tokyo are working on vaccine development.

In addition, overseas, research institutions and pharmaceutical companies such as the United States and the United Kingdom have announced that they have started developing vaccines one after another, and the Chinese government has revealed the prospect that clinical trials can be started as early as late next month. .